Standout Papers

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hype... 1996 2026 2006 2016 3.9k
  1. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial (1998)
    Lennart Hansson, Alberto Zanchetti et al. The Lancet
  2. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002)
    Björn Dahlöf, Richard B. Devereux et al. The Lancet
  3. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery (2004)
    Lars Sjöström, Anna‐Karin Lindroos et al. New England Journal of Medicine
  4. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures (1996)
    Deborah A. Marshall, O. Johnell et al. BMJ
  5. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial (2003)
    Peter Sever, Björn Dahlöf et al. The Lancet
  6. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial (2005)
    Björn Dahlöf, Peter Sever et al. The Lancet
  7. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol (2002)
    Lars Lindholm, Hans Ibsen et al. The Lancet
  8. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year (1995)
    Klas Malmberg, Lars Rydén et al. Journal of the American College of Cardiology
  9. EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION (1981)
    Åke Hjalmarson, Johan Herlitz et al. The Lancet
  10. Excess Mortality among Persons with Type 2 Diabetes (2015)
    Mauro Tancredi, Annika Rosengren et al. New England Journal of Medicine
  11. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity (2005)
    K. Malmberg, Lars Rydén et al. European Heart Journal
  12. Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications (2014)
    Lars Sjöström, Markku Peltonen et al. JAMA
  13. Effects of the Early Administration of Enalapril on Mortality in Patients with Acute Myocardial Infarction (1992)
    Peter Held, J Kjekshus et al. New England Journal of Medicine
  14. Glycemic Control and Excess Mortality in Type 1 Diabetes (2014)
    Marcus Lind, Ann‐Marie Svensson et al. New England Journal of Medicine
  15. Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction (1999)
    Klas Malmberg, Anna Norhammar et al. Circulation
  16. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects (2012)
    Lena Carlsson, Markku Peltonen et al. New England Journal of Medicine
  17. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections (2017)
    Marcus Lind, William H. Polonsky et al. JAMA
  18. Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. (1990)
    Annika Rosengren, Lars Wilhelmsen et al. BMJ
  19. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014)
    Dipak Kotecha, Jane Holmes et al. The Lancet

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 224 standout
Sub-graph 1 of 13

Citing Papers

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
2017 Standout
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017 Standout
49 intermediate papers

Works of Hans Wedel being referenced

Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications
2014 Standout
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
2004 Standout
and 8 more

Author Peers

Author Last Decade Papers Cites
Hans Wedel 21117 14602 14372 265 42.9k
Curt D. Furberg 17052 8716 8595 335 37.4k
Michael H. Criqui 12426 8648 21878 490 42.9k
Philip Greenland 19627 7126 12931 446 43.6k
Glenn M. Chertow 11265 7416 11913 800 67.2k
Lars Wilhelmsen 12388 7940 8819 390 31.1k
John W. Kusek 12694 6522 8987 366 58.5k
William P. Castelli 16394 12676 11423 122 37.1k
Neil J. Stone 14922 13998 18539 187 44.0k
Christopher J. O’Donnell 16288 5252 6703 331 36.7k
Roger S. Blumenthal 19874 8551 11826 745 43.0k

All Works

Loading papers...

Rankless by CCL
2026